| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.4M | -24.3% |
| R&D Expense | $1.1M | -57.1% |
| SG&A Expense | $10.3M | -66.9% |
| Operating Income | -$13.9M | +69.0% |
| Pre-tax Income | -$15.5M | +71.7% |
| Income Tax | $30K | -36.2% |
| Net Income | -$15.2M | +89.2% |
| EPS (Basic) | -$173.97 | -2289.7% |
| EPS (Diluted) | -$175.99 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.4M | +114.9% |
| Accounts Receivable | $1.7M | +1.6% |
| Inventory | $2.0M | -53.6% |
| Current Assets | $11.5M | -29.2% |
| Total Assets | $21.7M | -21.2% |
| Current Liabilities | $10.0M | -60.2% |
| Long-term Debt | $6.7M | -52.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.3M | +73.9% |
| Capital Expenditures | $141K | -97.0% |
| Investing Cash Flow | -$139K | -100.8% |
| Financing Cash Flow | $16.8M | -54.7% |
| Free Cash Flow | -$14.5M | +75.7% |
| -2317.4% |
| Total Liabilities |
| $17.7M |
| -50.8% |
| Stockholders' Equity | $4.0M | +147.7% |